Inorganic Chemistry
Article
crystallography was performed at the SCXRD laboratory of the
Catalysis Research Center.
K): δ [ppm] = 152.8, 151.0, 144.9, 141.9, 137.6, 133.6, 133.5, 129.6,
126.5, 125.1, 124.0, 122.9, 121.3, 115.4, 113.1, 24.8, 14.6. Anal. Calcd
for C23H24N2: C, 84.11; H, 7.37; N, 8.53. Found C, 83.83; H, 7.60; N,
8.24. MS (EI, 70 eV): 329.2 m/z [M + H].
Ligands. 2-Triflatotropone. This compound was synthesized
according to a modified literature procedure.21 2-Hydroxycyclohep-
ta-2,4,6-trienone (tropolone) (2.50 g, 20.5 mmol, 1.00 equiv),
triethylamine (2.17 g, 21.5 mmol, 1.05 equiv), and N-phenyltriflimide
(7.68 g, 21.5 mmol, 1.05 equiv) were dissolved in dry dichloro-
methane and stirred for 48 h at r.t. After extraction with water (20
mL) and dichloromethane (2 × 20 mL), the main product was
concentrated in vacuo and purified via silica gel column chromatog-
raphy (hexane/ethyl acetate = 2:1, TLC Rf = 0.3) yielding a brownish
oil (86%). 1H NMR (500 MHz, CDCl3, 298 K): δ (ppm) = 9.07 (br
N-Phenyl-2-(2,6-diisophenylamino)troponimine 3b. 1H NMR
(500 MHz, CDCl3, 298 K): δ (ppm) = 9.16 (br s, 1H, NH), 7.46
(t, J = 7.9 Hz, 2H), 7.28−7.17 (m, 6H), 6.93 (d, J = 11.0 Hz, 1H),
6.77 (dd, J = 10.7 Hz, J = 9.6 Hz, 1H), 6.69 (dd, J = 10.7 Hz, J = 9.6
Hz, 1H) 6.31 (t, J = 9.6 Hz, 1H), 6.19 (d, J = 10.7 Hz, 1H), 2.97−
2.89 (m, 2H), 1.20 (dd, J = 11.1 Hz, 6.9 Hz, 12H). 13C NMR (126
MHz, CDCl3, 298 K): δ [ppm] = 151.3, 145.4, 142.6, 140.0, 133.5,
133.5, 129.6, 125.7, 123.9, 123.8, 122.8, 121.3, 115.1, 113.9, 28.5,
24.2, 23.5. Anal. Calcd for C25H28N2: C, 84.23; H, 7.92; N, 7.86.
Found C, 84.24; H, 8.29; N, 7.57. MS (EI, 70 eV): 357.3 m/z [M +
H].
s, OH), 7.42−7.22 (m, 4H, HAr), 7.07 (t, J = 10.2 Hz, 1H, HAr). 13
C
NMR (126 MHz, CDCl3, 298 K): δ [ppm] = 178.5 (s), 156.4 (s),
141.2 (s), 137.6 (s), 136.4 (s), 130.7 (s), 128.6 (s), 121.4 (1JCF = 323
Hz).
N-(Phenylimino)pent-2-en-2-yl)aniline (4a). The ligand was
synthesized by a modified literature procedure.19 A solution of 2,4-
pentadione (5.00 g, 49.9 mmol, 1.00 equiv) and aniline (9.18 g, 100
mmol, 2.00 equiv) was treated with concentrated hydrochloric acid
(4.90 g, 49.9 mmol) at 0 °C. After stirring the mixture for 24 h, the
precipitate was filtered, washed with hexane, and dissolved in a
solution of CH2Cl2 (4 mL), H2O, and triethylamine (10.0 mL). The
Aromatic 2-Aminotropones (1a−3a). In a preheated Schlenk
flask, 2-triflatotropone (1.20 g, 4.72 mmol, 1.00 equiv), cesium
carbonate (2.15 g, 6.61 g, 1.40 equiv), rac-2,2′-bis-
(diphenylphosphino)-1,1′-binaphthalene (29.4 mg, 47.2 μmol, 0.01
equiv), tris(dibenzylideneacetone)dipalladium (21.6 mg, 23.6 μmol,
0.005 equiv), and the respective aniline (6.14 mmol, 1.30 equiv) were
dissolved in toluene and heated to 90 °C for 24 h.16 The crude
product was filtered, concentrated in vacuo, and purified via silica gel
chromatography (hexane/ethyl acetate = 20:1, TLC Rf = 0.2).
1
crude product was recrystallized from ethanol. H NMR (500 MHz,
CDCl3, 298 K): δ (ppm) = 12.7 (s, 1H, NH), 7.29 (m, 4H, HAr), 7.06
(t, J = 7.4 Hz, 2H, HAr), 6.97 (d, J = 8.5 Hz, 4H, HAr), 4.89 (s, 1H,
CH), 2.01 (s, 6H, CH3).
1
2-(Phenylamino)tropone 1a. H NMR (500 MHz, CDCl3, 298
K): δ (ppm) = 8.84 (br s, 1H, NH), 7.53−7.19 (m, 9H, HAr), 6.88
(dd, J = 7.1 Hz, J = 8.9 Hz, 1H, HAr).
Complexes. The ligands 1b−3b (0.610 mmol, 1.00 equiv) were
dissolved in a Schlenk flask in 10 mL of toluene. Zn(NTMS2)2 (0.670
mmol, 1.10 equiv) was added to the solution and stirred for 3 h
(ligand 3a for 24 h in the case of 0 °C/25 °C and 72 h at 100 °C) at
room temperature; then the solvent was removed in vacuo. Complexes
II and III were obtained by recrystallization in CH2Cl2/pentane at
−35 °C. Complexation of 1b yielded 50% homoleptic and 50%
heteroleptic complex. Recrystallization of a saturated solution in
CH2Cl2/pentane resulted in the exclusive crystallization of the
homoleptic complex, whereas the heteroleptic one remains in solution
and can be successfully separated.
2-(2,6-Diethylphenylamino)tropone 2a. 1H NMR (500 MHz,
CDCl3, 298 K): δ (ppm) = 8.47 (br s, 1H, NH), 7.36−7.23 (m, 5H,
HAr), 7.07 (t, J = 10.3 Hz, 1H, HAr), 6.73 (t, J = 8.9 Hz, 1H, HAr), 6.26
(d, J = 10.3 Hz, 1H, HAr), 2.55−2.42 (m, 4H, −CH2−), 1.14 (t, J =
7.6 Hz, 6H, −CH3). 13C NMR (126 MHz, CDCl3, 298 K): δ [ppm] =
176.5, 155.6, 142.1, 137.5, 136.7, 133.9, 129.8, 128.4, 127.0, 123.6,
110.2, 24.7, 14.9. Anal. Calcd for C17H19NO: C, 80.60; H, 7.56; N,
5.53. Found C, 80.67; H, 7.64; N, 5.46. MS (EI, 70 eV): 253.2 m/z
[M+].
2-(2,6-Diisopropylphenylamino)tropone 3a. 1H NMR (500
MHz, CDCl3, 298 K): δ (ppm) = 8.42 (br s, 1H, NH), 7.41−7.26
(m, 5H, HAr), 7.07 (t, J = 10.3 Hz, 1H, HAr) 6.73 (t, J = 9.8 Hz, 1H,
HAr), 6.27 (d, J = 10.3 Hz, 1H, HAr) 2.94−2.85 (m, 2H, −CH−), 1.13
(dd, J = 20.3 Hz, J = 6.9 Hz, 6H, −CH3). 13C NMR (126 MHz,
CDCl3, 298 K): δ [ppm] = 176.4, 156.5, 146.9, 137.7, 136.4, 132.4,
130.0, 128.9, 124.4, 123.8, 110.7, 28.6, 24.6, 23.5. Anal. Calcd for
C19H16N2: C, 81.10; H, 8.24; N, 4.98. Found C, 81.10; H, 8.47; N,
4.74. MS (EI, 70 eV): 281.2 m/z [M+].
N,N′-Disubstituted Aminotroponimines (1b−3b). Triethy-
loxonium tetrafluoroborate (0.47 g, 2.48 mmol, 1.05 equiv) was
dissolved in a preheated flask in dry dichloromethane and added to a
solution of the respective 2-aminotropone 2a−c (2.36 mmol, 1.00
equiv) and dichloromethane. After stirring for 3 h at r.t., aniline (1.10
g, 11.4 mmol, 5.00 equiv) was added and the resulting solution was
stirred for 48 h. The crude product was extracted with a NaOH
solution (1M, 10 mL) and dichloromethane (2 × 10 mL). A dark
brownish oil was obtained after silica gel column chromatography
(hexane/ethyl acetate = 30:1, TLC Rf = 0.6).
I. 1H NMR (300 MHz, CDCl3, 298 K): δ [ppm] = 7.46 (t, J = 9.6
Hz, 4H, HAr), 7.22 (t, J = 7.3 Hz, 2H, HAr), 7.14 (dd, J = 7.4 Hz, J =
1.1 Hz, 4H, HAr), 7.07 (m, 3H, HAr), 6.72 (m, 2H, HAr), −0.18 (s,
18H, Si−CH3). 13C NMR (126 MHz, CDCl3, 298 K): δ [ppm] =
160.3, 159.7, 149.4, 148.1, 135.2, 134.8, 129.9, 129.8, 124.8, 124.5,
124.1, 122.3, 117.6, 116.2. Anal. Calcd for C25H33N3Si2Zn: C, 60.40;
H, 6.69; N, 8.45. Found C, 60.09; H, 6.79; N, 8.59.
II. 1H NMR (500 MHz, CDCl3, 298 K): δ (ppm) = 7.46 (t, J = 7.9
Hz, 2H, HAr), 7.25−7.00 (m, 9H, HAr), 6.57 (t, J = 9.2 Hz, 1H, HAr),
6.53 (d, J = 11.2 Hz, 1H, HAr), 2.55−2.37 (m, 4H, −CH2−), 1.15 (t, J
= 7.6 Hz, 6H, −CH3), −0.25 (s, 18H, Si−CH3). 13C NMR (126
MHz, CDCl3, 298 K): δ [ppm] = 159.5, 159.0, 147.8, 143.7, 137.2,
135.1, 135.0, 129.7, 126.2, 125.2, 125.0, 124.7, 121.8, 117.2, 116.7,
23.9, 14.0, 4.65. Anal. Calcd for C29H41N3Si2Zn: C, 62.96; H, 7.47; N,
7.60. Found C, 62.63; H, 7.43; N, 7.30.
1
III. H NMR (500 MHz, CDCl3, 298 K): δ (ppm) = 7.46 (t, J =
7.9 Hz, 2H, HAr), 7.26−6.97 (m, 7H, HAr), 7.07 (t, J = 10.7 Hz, 1H,
HAr), 6.99 (t, J = 10.5 Hz, 1H, HAr), 6.55 (t, J = 9.4 Hz, 2H, HAr), 2.87
(m, 2H, CH), 1.22 (d, J = 6.8 Hz, 6H, CH3), 1.04 (d, J = 6.8 Hz, 6H,
CH3), −0.23 (s, 18H, Si−CH3). 13C NMR (126 MHz, CDCl3, 298
K): δ [ppm] = 160.7, 159.0, 147.6, 142.6, 142.3, 135.2, 134.8, 129.8,
125.9, 125.1, 124.8, 124.4, 122.0, 118.5, 116.9, 28.4, 25.4, 24.3, 4.78.
Anal. Calcd for C31H45N3Si2Zn: C, 64.06; H, 7.80; N, 7.23. Found C,
63.96; H, 7.79; N, 6.96.
N-Phenyl-2-(phenylamino)troponimine 1b. 1H NMR (500 MHz,
CDCl3, 298 K): δ (ppm) = 9.18 (br s, 1H, NH), 7.40 (t, J = 7.9 Hz,
4H), 7.16−7.12 (m, 6H), 6.84 (d, J = 10.4 Hz, 2H, HAr), 6.73 (t, J =
10.3 Hz, 2H, HAr), 6.34 (t, J = 9.2 Hz, 1H). 13C NMR (126 MHz,
CDCl3, 298 K): δ [ppm] = 152.0, 145.3, 133.6, 129.6, 124.1, 122.7,
122.2, 115.0. Anal. Calcd for C19H16N2: C, 83.79; H, 5.92; N, 10.29.
Found C, 83.95; H, 6.00; N, 10.23. MS (EI, 70 eV): 273.2 m/z [M +
H].
Ligand 4a (0.68 mmol, 1.0 equiv) was dissolved in 5.0 mL of
toluene. Zn(NTMS2)2 (0.82 mmol, 1.2 equiv) was added to the
solution and stirred for 20 h at 80 °C; then the solvent was removed
in vacuo. Complex IV was obtained via recrystallization in toluene at
1
N-Phenyl-2-(2,6-diethylphenylamino)troponimine 2b. H NMR
(500 MHz, CDCl3, 298 K): δ (ppm) = 9.10 (br s, 1H, NH), 7.41 (t, J
= 7.8 Hz, 2H), 7.18−7.13 (m, 6H), 6.88 (d, J = 10.9 Hz, 1H), 6.73
(dd, J = 10.6 Hz, J = 9.5 Hz, 1H), 6.66 (dd, J = 10.6 Hz, J = 9.5 Hz,
1H), 6.28 (t, J = 9.5 Hz, 1H), 6.14 (d, J = 10.6 Hz, 1H), 2.53−2.39
(m, 4H), 7.54 (t, J = 7.5 Hz, 6H). 13C NMR (126 MHz, CDCl3, 298
1
−35 °C. IV. H NMR (500 MHz, CDCl3, 298 K): δ (ppm) = 7.33
(m, 4H, HAr), 7.15 (t, J = 7.4 Hz, 2H, HAr), 6.98 (d, J = 8.2 Hz, 4H,
HAr), 4.91 (s, 1H, CH), 1.95 (s, 6H, CH3), −0.33 (s, 18H, Si−CH3).
13C NMR (126 MHz, CDCl3, 298 K): δ [ppm] = 167.8, 148.7, 128.9,
H
Inorg. Chem. XXXX, XXX, XXX−XXX